Resistance to antiretroviral drugs remains an important limitation to successful human
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …

The use of chemotherapy to suppress replication of the human immunodeficiency virus (HIV)
has transformed the face of AIDS in the developed world. Pronounced reductions in illness …

The HIV reverse transcriptase and protease sequence database is an on-line relational
database that catalogues evolutionary and drug-related sequence variation in the human …

Background Since the introduction of highly active antiretroviral therapy (HAART), little is
known about whether changes in HIV-1 mortality and morbidity rates have been sustained …

Background Among persons in North America who are newly infected with the human
immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs …

The most effective means of preventing human immunodeficiency virus (HIV) infection is
preventing exposure. The provision of antiretroviral drugs to prevent HIV infection after …

Background: Although the use of highly active antiretroviral therapy in the treatment of HIV
infection has led to considerable improvement in morbidity and mortality, unless patients are …

Background Lopinavir is a newly developed inhibitor of human immunodeficiency virus
(HIV) protease that, when formulated with ritonavir, yields mean trough plasma lopinavir …

Objective. The objective of this study was to systematically characterize the incidence and
determinants of antiretroviral resistance in the HOMER (Highly Active Antiretroviral Therapy …

ObjectiveNew information warrants updated recommendations for the 4 central issues in
antiretroviral therapy: when to start, what drugs to start with, when to change, and what to …